Genital Herpes
29
0
0
20
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
12 trials with published results (41%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
17.2%
5 terminated out of 29 trials
80.0%
-6.5% vs benchmark
41%
12 trials in Phase 3/4
60%
12 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (29)
A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
Effect of HSV-2 Suppressive Therapy on Sexual Behavior
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
Knowledge of Young Adults About Genital Herpes
Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2
A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621
Melatonin Effects on Genital Herpes in Brazilian Women
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
The VIBLOK SAfety and perFormancE Trial
Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes